These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3865030)

  • 1. Cytogenetics and cell surface marker analysis in CML--1. Prediction of phenotype of acute phase transformation.
    Ligler FS; Brodsky I; Schlam ML; Fuscaldo KE
    Leuk Res; 1985; 9(9):1093-8. PubMed ID: 3865030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics and flow cytometry may predict phenotype of CML blast crisis.
    Ligler FS; Brodsky I; Schlam ML; Fuscaldo KE
    Cancer Detect Prev; 1985; 8(1-2):317-23. PubMed ID: 3864537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics and cell surface marker analysis in chronic myelocytic leukemia. II. Implications for patient management.
    Fuscaldo KE; Brodsky I; Crilley P; Ligler FS
    Cancer Genet Cytogenet; 1987 May; 26(1):25-37. PubMed ID: 3470134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chromosomes and causation of human cancer and leukemia. XVIII. The missing Y in acute myeloblastic leukemia (AML) and Ph1-positive chronic myelocytic leukemia (CML).
    Sakurai M; Sandberg AA
    Cancer; 1976 Aug; 38(2):762-9. PubMed ID: 1067892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferentially expressed genes in chronic myelogenous leukemia.
    Mars WM; Florine DL; Talpaz M; Saunders GF
    Blood; 1985 May; 65(5):1218-25. PubMed ID: 2581635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomes and causation of human cancer and leukemia. XXV. Significance of the Ph1 (including unusual translocations) in various acute leukemias.
    Oshimura M; Sandberg AA
    Cancer; 1977 Sep; 40(3):1149-60. PubMed ID: 332321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
    Childs CC; Hirsch-Ginsberg C; Walters RS; Andersson BS; Reuben J; Trujillo JM; Cork A; Stass SA; Freireich EJ; Zipf TF
    Leukemia; 1989 Nov; 3(11):777-83. PubMed ID: 2811478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1-negative chronic myelocytic leukemia (CML).
    Kohno S; Abe S; Sandberg AA
    Am J Hematol; 1979; 7(3):281-91. PubMed ID: 296877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal evolution of karyotype in blastic phase of CML.
    Izakovic V; Horák I; Krizan P
    Neoplasma; 1982; 29(5):613-23. PubMed ID: 6960260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia.
    Nitta M; Kato Y; Strife A; Wachter M; Fried J; Perez A; Jhanwar S; Duigou-Osterndorf R; Chaganti RS; Clarkson B
    Blood; 1985 Nov; 66(5):1053-61. PubMed ID: 2996659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of cytogenetic studies in prediction of acute phase CML.
    Watmore AE; Potter AM; Sokol RJ; Wood JK
    Cancer Genet Cytogenet; 1985 Jan; 14(3-4):293-301. PubMed ID: 3855370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sister chromatid exchange in Philadelphia chromosome (Ph1)-positive leukemia.
    Kakati S; Abe S; Sandberg AA
    Cancer Res; 1978 Sep; 38(9):2918-21. PubMed ID: 277286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte markers and the common acute lymphoblastic leukemia antigen on chronic lymphocytic leukemia cells.
    Ligler FS; Schlam ML; Curley R; Brodsky I; Benzel JE
    Am J Hematol; 1983 Dec; 15(4):335-42. PubMed ID: 6196965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Triple Philadelphia chromosome during blastic crisis of a chronic myelocytic leukemia].
    Cabrol C; Peytremann R; Maurice PA; Klein D
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1381. PubMed ID: 1070157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blast crisis of Philadelphia chromosome-positive chronic myelocytic leukemia (CML). Treatment results of 69 patients.
    Anger B; Carbonell F; Braunger I; Heinze B; Gutensohn W; Thiel E; Heimpel H
    Blut; 1988 Sep; 57(3):131-7. PubMed ID: 3166389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early T-cell features in blast crisis of Ph1-positive chronic myeloid leukaemia.
    Cervantes F; Anegon I; Rozman C; Gallart T; Pereira A; Vives-Corrons JL; Casademont J; Urbano-Marquez A
    Scand J Haematol; 1985 Jul; 35(1):71-6. PubMed ID: 3931208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomes and causation of human cancer and leukemia. XXIX. Further studies on karyotypic progression in CML.
    Sonta S; Sandberg AA
    Cancer; 1978 Jan; 41(1):153-63. PubMed ID: 272225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do chromosome abnormalities determine the type of acute leukemia that develops in CML?
    Bernstein R; Gale RP
    Leukemia; 1990 Jan; 4(1):65-8. PubMed ID: 2296202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotype of clonogenic cells in myeloid leukaemia.
    Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
    Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.